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Introduction
The naturally occurring polyamines spermine, spermidine, and the diamine putrescine are widely distributed in nature (2,5,19,29). These polycations have been implicated in many growth and differentiation processes (9) . In general, their intracellular levels rise during proliferation processes such as embryogenesis (3), liver regeneration (23), and during malignant transformation (26). This increase in cellular polyamine concentrations has been attributed to the activation of ornithine decarboxylase (ODC; E.C. 4.1.1.17), which catalyzes the conversion of ornithine to putrescine, the ratelimiting step in polyamine biosynthesis (25). Thus, ODC can reflect growth rates (31). For determining the activity of ODC at least lo6 cells are required. In many cases the detection of ODC in individual cells is advantageous. It has been well established that ODC has a very short half-life (15-30 min), the shortest half-life of any known eukaryotic enzyme (24). Therefore, using immunological procedures to detect ODC protein would reflect the presence of active enzyme and would indicate whether the cell is proliferating. Several immunochemical (8,12,15,21) and chemical methods (1) for the detection of ODC have been described, but none of them permits the quantitative estimation of the protein. Supported In this communication we describe a quantitative immunofluorometric method for the detection of ODC in individual cells. This method could be used for the assessment of proliferation or, conversely, for the determination of growth arrest. We suggest that such a method could be used for an in vitro chemosensitivity test to determine the sensitivity of tumor cells to anti-cancer agents.
Materials and Methods
Cell Cultures. KB-3-1 wild-type human epithelial carcinoma cells were kindlyprovided by Dr. Y. Assaraf(T*on, Hiufa, Israel). KB-V-1 multidrug resistant (MDR) human epithelial carcinoma cells were also obtained from Dr. Assaraf.
KB-3-1 and KB-V-1 were grown in Dulbecco's modified Eagle's medium (DMEM) (Beth-Haemek; Israel) containing 4.5 glliter D-glucose supplemented with 5% fetal calf serum (Gibco; Grand Island, NY), 1% Lglutamine (Bio-lab Jerusalem, Israel). 400 U/ml penicillin, and 0.4 mg/ml streptomycin (Bio-lab).
NIH 3T3 mouse fibroblasts were uansfected with the oncogene c-Haras as described by Katz and Carter (13) and co-transfected with 2300 BP of neomycin gene (neo) cloned in puc 18 plasmid. CO-transfection was done in a ratio of 1O:l of c-Ha-ras:neo. Transfected clones were selected by growing the cells in DMEM medium in the presence of 0.8 mg/ml geneticin (Gibco). Cellswcre grown in DMEM medium containing 4.5 glliter D-ghcose (Beth-Haemek, Israel), 2% fetal calfserum (Beth-Haemek), 1% Lglutamine (Bio-lab), 400 U/ml penicillin, and 0.4 m g / d streptomycin (Bio-lab). Cells were seeded onto coverslips placed in 100-mm-diameter tissue culture dishes in 10 ml medium. Cells were grown for 24-48 hr in a 5% CO2 incubator at 95% air. Drug was added for 3 or 24 hr.
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Fixation and permeabilization. Cells on the cmrslips were washed with PBS, pH 7.4, at room temperature, fixed for 30 min by 3% paraformaldehyde (BDH; Poole, UK), pH 6.1, and washed three times with PBS for 2 min each.
Permeabilization was done with 0.5% TritonX-100 (Mer& Darmstadt, Germany) in PBS for 5 min. After permeabilization, cells were washed again with PBS.
Antibody Labeling. Anti-ODC rabbit antibodies (kindly provided by Dr. H. Kahana, The Weizmann Institute of Science, Rehwot, Israel), were diluted 1100 in PBS and l o -~l droplets were placed on the coverslips carrying the cells. After incubation for 1 hr, cells were washed three times for I c' L 2a 10 min each with PBS and incubated for 30 min with 10-~1 droplets of FIE-conjugated secondary goat anti-rabbit antibody (Jackson; West Grove, PA) diluted k30 in PBS. Cells on the coverslips were then washed thee times (10 min each) with PBS, fmally mounted in 90% glycerol, 10% 1 M Tris-HC1, pH 8.8 (Sigma; St Louis, MO), and screened by fluorescence microscopy.
Fluorescence Scmning. Cells were screened with an ACAS 570 computerized fluorescence microscope (Meridian; Okemos, MI) equipped with a water-cooled argon laser beam (Coherent), model Innova 90. Excitation was at 488 nm (100 mW) and emission was detected at 530 nm. Emission was quantitated by an IBM computer (DOS 5.0) attached to the microscope. 
Results
A quantitative immunohistochemical method was used to detect ODC protein in individual human wild type epithelial carcinoma cells (KB-3-1) and KB-V-1 multidrug-resistant (MDR) variants.
Drug-sensitive KB-3-1 cells were grown in the absence of vinblastine for 48 hr, fixed, and treated with anti-ODC antibody fol- On the other hand, when after 24 hr of incubation those drug-sensitive cells were exposed to vinblastine (0.5 pglml) for an additional 24 hr, no fluorescence could be detected ( Figure  Ib) . Moreover, fluorescence was detected in MDR cells (KB-V-1) grown in the absence of vinblastine under the same conditions as described above ( Figure IC) and also in cells subjected to the drug for 24 hr ( Figure Id) . To confirm the generality of the procedure, the presence of ODC protein was tested in NIH 3T3 cells transfected with the oncogene c-Ha-ras. Cells were grown for 24 hr, after which they were treated with cycloheximide (10 Vglml) for 3 hr and the ODC protein level was determined. Fluorescence was obvious in untreated cells (Figure le) but disappeared in cycloheximide-treated cells ( Figure If) .
To test the specificity of the assay, suitable controls were run. These included studies in which cells were not treated with antibodies (Figure 2a ). were treated with ODC antibodies only ( Figure  2b ), were treated with FITC-conjugated second antibodies only (Figure 2c) , or were treated with serum obtained from normal rabbits (pre-immune serum) followed by FITC second antibodies (Figure 2d) .
Specific cells could be identified by comparing fluorescence 3a and 3b) . The data shown in Figures 1 and 2 can provide a semiquantitative estimation of the amount of ODC in the cells. This is done by comparing the color of the stained cells with the standard color scale. Definitive quantitative results can be obtained by using computerized image processing. A typical analysis (Figure 4a) showed that untreated c-Ha-ras cells contained variable amounts of fluorexent material, with wide shoulders and a peak at the pixel value of 900. On the other hand, quantitative analysis of cycloheximidetreated cells (Figure 4b) showed less fluorescent material, most of it within the background values with a sharp peak at the pixel value of 400.
To compare the ODC staining technique with another reliable method that determines proliferation, wild-type KB-3-1 cells were grown, synchronized, and treated with vinblastine as described under Methods. Gble 1 shows that 0.5 pg/ml of vinblastine inhibited the incorporation of [3H]-thymidine into cellular DNA. After 24 hr the incorporation was inhibited by 73% and by 98% only after 36 hr. The results illustrated in Figures la and 1b suggest that ODC protein completely disappeared in cells treated with the drug for 24 hr. These findings thus support the notion that ODC staining can be used as an early marker for proliferation and might possibly be applied for chemosensitivity testing.
Discussion
Omithine decarboxylase, the most important rate-controlling enzyme in polyamine biosynthesis, is closely associated with mammalian cell proliferation and neoplastic transformation (18, 20, 30) . Many studies have demonstrated that ODC activity is substantially increased in tumors (28), transformed cells (7, 11, 17) , and, in some cases, in tissues predisposed to malignant transformation (1416). ODC mRNA levels are also elevated in uansformed cells including lung carcinomas (4) and human colon adenomas and carcinomas (10) . It is of special interest that both ODC activity and mRNA levels are enhanced in human colon adenoma and carcinoma cells relative to pathologically uninvolved adjacent mucosa and control mucosa (22) .
These observations suggest that the ODC gene is important in the development and maintenance of neoplastic growth. This consideration and the finding that ODC has an extremely short halflife (15-30 min) (27) strongly support the notion that this enzyme can serve as a marker for growth in general and as an indicator for malignancies in particular. Moreover, ODC could serve as a useful marker for the in viuo assessment of cytotoxicity.
ODC can be estimated by measuring the activity of the enzyme. The widely used isotopic method (6) for the assay of ODC activity is relatively simple but requires at least lo6 cells. This method is therefore not suitable for the detection of ODC in individual cells.
The immunohistochemical method described here permits the detection and quantitation of ODC in individual cells. This method is based on the finding that fluorescence was detected in all untreated cells (Figures la, IC, and le) but not in drug-sensitive KB-3-1 cells treated with vinblastine ( Figure 1b) . Similarly, ODC protein was not detected in cells when protein synthesis was arrested by cycloheximide ( Figure lf) .
To demonstrate that ODC staining can be used as a marker of proliferation, this marker was compared to another indicator of proliferation, i.e., protein content. Wild-type human epithelial carcinoma KB-3-1 cells and multidrug-resistant epithelial carcinoma KB-V-1 cells were treated with 0.5 Bg/ml vinblastine. The growth of the drug-sensitive culture was not inhibited during the first 14 hr after drug treatment (results not shown). Thereafter, the growth was arrested and cellular protein did not increase in the presence of the drug. It should be noted that the activity of ODC in the drug-sensitive cells was inhibited as early as 10 hr after drug treatment (results not shown). The results depicted in Eble 1 also show that ODC staining is a sensitive and early marker of proliferation.
This simple and rapid method for measuring the cellular level of ODC could facilitate the quantitative assay of ODC protein. Moreover, our proposed method also enables the identification of a specific type of cell within a mixed population, as demonstrated by comparing Figures la and IC to Figures 3a and 3b . Therefore, it could be used for (a) differentiation between neoplastic and normal cells in biopsy material (mainly colon), (b) determination of chemo-or radiosensitivity of individual cells, and (c) determination of the mode of action of cytotoxic or cytostatic drugs. Cytotoxicity could be distinguished from the cytostatic state if ODC reappears after the removal of the drugs. Similarly, the disappearance of ODC after a short exposure of the cells to the drug would suggest that it is readily taken up by the cells, does not require a longterm depletion of an essential metabolite(s), and probably does not interfere with events related to the S-phase of the cell cycle. The method could also be used to study the effect of modulators during cancer chemotherapy.
We are fully aware that the ACAS-based method cannot be used for routine analysis. Work is now in progress to simpllfy the procedure and to use regular microscopic procedures for the detection of ODC in individual cells.
